Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations.

International journal of cardiology - 1 Sept 2011

Meune Christophe, Wahbi Karim, Gobeaux Camille, Duboc Denis, Pecker Françoise, Bonne Gisèle

Abstract excerpt

BACKGROUND: Recently, concerns have been raised about a possible lack of sensitivity of biomarkers to detect left ventricular (LV) dysfunction in patients with myopathies. We examined the ability of the N-terminal brain natriuretic peptide (NT-proBNP) to detect LV or right ventricular (RV) dysfunction in patients with lamin A/C (LMNA) gene mutations. METHODS: We prospectively measured plasma NT-proBNP in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamin Type A

Share to Myocardial Contraction

Share to Natriuretic Peptide, Brain

Share to Peptide Fragments

Share to Prognosis

Share to Ventricular Dysfunction, Left

Source

Identifiers

PMID: 20627339
DOI: 10.1016/j.ijcard.2010.05.005

Genes

LMNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations.PMID 20627339Read ↗

Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype.Semantic proximity Read ↗

Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.Semantic proximity Read ↗

Meta-analysis of the role of cardiac magnetic resonance in laminopathy.Semantic proximity Read ↗

Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction.Semantic proximity Read ↗

Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects.Semantic proximity Read ↗

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?Semantic proximity Read ↗

Progression of cardiac disease in patients with lamin A/C mutations.Semantic proximity Read ↗

Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations.Semantic proximity Read ↗

Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.Semantic proximity Read ↗

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?Semantic proximity Read ↗

Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.Semantic proximity Read ↗

Myocardial fibrosis as a early cardiac marker of disease in patients with lamin A/C mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.